Corporate Reputations Improve During a Year of Crises according to The RepTrak Company
12.4.2021 12:00:00 EEST | Business Wire | Press release
The RepTrak Company™, the world’s leading reputation data and insights company, announces the results of the 2021 Global RepTrak® 100. The report is the world’s most comprehensive reputation study, compiled for the past 11 years using RepTrak’s in-depth analysis and ranking of the top 100 companies worldwide by Reputation Score.
In 2021, RepTrak found that, overall, it was a much more difficult year to break into the top 100. The average score (on a scale of 1-100) was almost 75, the highest in 11 years. This is an indication of the rigorous reputation management in place among these leaders. Several of the companies that rank highest in the 2021 Global RepTrak 100 are those that have implemented ESG (Environment, Societal impact and Governance) initiatives within their global strategies.
Notable findings include:
- Being relevant mattered in a difficult year. Consumer durables and apparel, technology (both hardware and software) and household and personal products companies lead the way after a year when the world depended on them for productivity, entertainment, comfort and safety.
- Pharmaceutical industry’s Reputation Score improved from “average” to “strong” with vaccines propelling positive perceptions. Sanofi S.A., Eli Lilly Company and Bristol Myers Squibb are among the top 10 for Reputation Score growth this year.
- ESG leadership went to the pharmaceutical and household and personal products industries. The global respondents credited their ESG initiatives more than any other industries, another indication of the importance of pandemic-centered relevance in 2020.
- GenZ (18-25) and Millennial (26-40) perceptions differ. GenZ perceives corporations with the greatest skepticism, as indicated by their weaker levels of support for the seven drivers of corporate reputation codified by RepTrak. Millennials were the most positive of all generational segments. GenX (41-55) and Boomers (56-64) fall in the middle and don’t differ greatly.
For the complete 2021 Global RepTrak 100 ranking and report, with comprehensive analysis of global, industry, and demographic trends, visit https://www.reptrak.com/rankings/
2021’s Reputation Leaders
The top 10 companies by Reputation Score, as ranked in the 2021 Global RepTrak® 100, are:
- The Lego Group
- Rolex SA
- Ferrari N.V.
- The Bosch Group
- Harley-Davidson, Inc.
- Canon Inc.
- adidas AG
- The Walt Disney Company
- Microsoft Corp.
- Sony Group Corp.
The Lego Group maintains its #1 ranking, showing a steady increase in Reputation Score over the last several years, with all others in the top 10 in a new position compared to last year’s report. These year over year changes indicate that a company must continually work to improve its reputation and stay relevant.
High Growth in a Challenging Year
The top ten (10) of the 100 companies rated by greatest reputation increases and positive movement in their ranking are: Unilever PLC; Mars, Incorporated; Cisco Systems, Inc.; The Samsung Group; Sanofi S.A.; Harley-Davidson, Inc.; HP Inc.; Procter & Gamble Company; Eli Lilly and Company; and Bristol Myers Squibb.
“At Cisco, we take our reputation seriously. Our purpose as a company is to power an inclusive future for all, and this drives everything we do. We believe it starts with the trust of our stakeholders to look after our people, our communities and our planet. This goes hand in hand with our relentless focus on innovation, to provide more choice and opportunities for our customers. The last year has been difficult for many, so it’s truly inspiring to be recognized for the impact we are making, and spurs us onwards to do more,” shared Gerri Elliot, EVP and Chief Sales and Marketing Officer at Cisco Systems, Inc.
“For Mars, building trust is a key business metric,” said Andy Pharoah, Vice President of Corporate Affairs & Sustainability at Mars, Incorporated, “And we believe maintaining a strong reputation is central to our ability to achieve our goals and live up to our purpose – that the world we want tomorrow starts with how we do business today. In the past year, which has been unlike any other, it’s more important than ever for businesses like Mars to communicate regularly and frequently with our stakeholders and Associates. Success is about navigating the challenges of the day with clarity, empathy and integrity. These results demonstrate that our efforts are having a positive impact, and are being recognized more broadly.”
Eighteen (18) companies are new to the Global RepTrak this year, the largest number of newcomers in the Global RepTrak 100 since its inception 11 years ago. These new entrants include luxury fashion leaders (Chanel Inc, Hermès, Prada Group, Burberry Group Plc), travel and automotive industry names (Volvo Group, Booking.com, Continental AG), consumer companies (Costco Wholesale Corporation, ALDI GmbH & Co. KG, Mattel, Inc.) and other leaders: Space Exploration Technologies Corp. (SpaceX), BIC, Adobe Systems, Hewlett Packard Enterprise, PayPal, Henkel AG & Co.
ESG rises in importance
ESG stands for Environmental, Social impact and Governance issues. The Global RepTrak 100 results clearly show that there is a strong correlation between companies that adhere to high ESG standards and companies that score favorably on the 2021 Global RepTrak 100.
“ESG is being used for the first time this year as a measurable component of reputation, and we can see firsthand why this is so important for 2021 and beyond. There is a strong correlation between companies who hold themselves to high standards, and companies who rank highly on the 2021 Global RepTrak® 100,” says Kylie Wright-Ford, CEO of The RepTrak Company. “Stakeholders have access to more information than ever before, which is empowering them to make more informed decisions. Companies must not only deliver a quality product, but also show that they are doing so in an ethical and globally considerate way.”
RepTrak is the only provider of data and insights around ESG perception at a global scale. For Environment, RepTrak looks at how companies are perceived with regard to climate change, the use of resources and the minimization of its carbon footprint. Social investigates perceptions of how companies lead on human rights, their participation in their local communities and how they handle employees and customers. Governance relates to the leadership, ethics and rights of shareholders and other stakeholders.
Report and Methodology
RepTrak helps companies understand how stakeholders feel, think, and act towards them, measuring reputation using a 0-100 scale and tracking how a company is perceived across several reputation drivers: Products & Services, Innovation, Citizenship, Performance, Governance, Leadership and Workplace. RepTrak’s proprietary measurement system has been developed to allow worldwide application on a normative scale, which enables direct comparison regardless of sector, size, or geography.
For consideration in the 2021 Global RepTrak® 100, a company had to meet the following criteria:
- Be a corporate brand with global revenue above USD $2 billion
- Achieve a global average familiarity threshold above 20 percent in all fifteen countries measured and a familiarity threshold above 20 percent in eight or more of the fifteen countries measured
- Reach a qualifying Reputation Score above the median score (i.e., 67.3 points)
To determine the ranking, The RepTrak Company analyzed reputation data for several thousand companies which was collected between December 2020 and January 2021 using world class survey methodology and was enriched by RepTrak’s historical database. Companies that met these criteria were then ranked based on their global Reputation Scores. A company’s corporate reputation is determined using RepTrak’s proprietary and patent-pending Reputation Score - a score from 0-100 that measures how people feel towards a particular company. Reputation Scores demonstrate a strong positive relationship with business outcomes, such as an audience’s willingness to buy, recommend, or trust a company. The top 100 companies with the highest Reputation Scores made the final ranking.
The Global RepTrak® 100 ranking is based on 68,577 respondents collected across the 15 largest economies globally using online surveys. For access to the report, visit https://www.reptrak.com/rankings/
About RepTrak
The RepTrak Company™ is the world’s leading reputation data and insights company. We provide the only global platform for data-driven insights on Reputation, Brand, and ESG. Our proprietary RepTrak® model is the global standard for measuring and analyzing the sentiment of the world using proven data science models and machine learning techniques across industries and geographies.
Subscribers to the RepTrak® Program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society.
Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database of over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit www.reptrak.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005413/en/
Contact information
PR Contact: Amanda Donnelly / PR Hacker / RepTrak@PRHacker.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 01:10:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of ORZEYFUL marks a new chapter for the narcolepsy type 1 community, as we introduce an entirely new class of medicine that will potentially redefine how this disease is managed and howpeople feel on treatment,” said Julie Kim, president and chief executive officer of Takeda. “We are proud to have discovered and developed this orexin treatment innovation and will bring it to adults living with NT1 as quickly as possible.” NT1 is a rare, chronic neurological disease d
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 23:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 17:05:00 EEST | Press release
Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership, and operational excellence with a track record of execution from first-in-human studies through regulatory
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation5.8.2026 16:37:00 EEST | Press release
Speech Processing Solutions, the global leader in AI-assisted professional dictation and documentation solutions sold under the Philips brand, today announced the Philips SpeechLive Legal AI Assistant. The new solution transforms voice recordings, dictation and uploaded sources into structured, ready-to-review legal documents, helping legal professionals work faster while retaining control of the final draft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805997413/en/ The new Philips SpeechLive Legal AI Assistant is designed for turning conversations into ready-to-review legal document drafts. SpeechLive Legal significantly reduces the time needed to transform voice input into structured legal documentation, delivering consistent and high-quality drafts and featuring SpeechLive's built-in integrations with leading case management platforms such as Actionstep, Clio, iManage and NetDocuments, supporting existing billing, e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
